Paul Clark

Paul Clark is a researcher at the Yale School of Medicine, with a strong publication record in immunology, vascular biology, and virology. His work spans from 1998 to 2022 and reflects deep engagement with molecular mechanisms of inflammation, endothelial function, and immune cell regulation.

Education:

• PhD, University of Arizona (1999)
• BS, University of Arizona (1985)

His research focuses on key areas including T cell metabolism, CAR-T therapy, endothelial barrier integrity, NF-κB signaling, and viral infection pathways. His studies often involve CRISPR screening, siRNA techniques, and analysis of inflammatory mediators such as TNF and ICAM-1.

The trajectory of his publications indicates a sustained focus on immunometabolism and cellular signaling, with recent contributions to enhancing cancer immunotherapies through metabolic modulation. His 2022 Cell Metabolism paper on proline metabolism in CD8 T cells highlights his role in cutting-edge cancer immunotherapy research.

Scientific Collaborators:

• Alexey Bersenev, MD, PhD
• Jordan Pober, MD, PhD
• Paula Preston-Hurlburt
• Ruth R. Montgomery, PhD
• Sidi Chen, PhD

He has not been listed as receiving any specific scientific awards in the provided text. He advises no named students in the available data. He is involved in laboratory-based research, likely within a collaborative immunology or vascular biology group at Yale, though specific lab or team names are not provided.